In a moment when medicine is being reshaped by both technology and biology, a study of half a million British adults has offered something rare: real-world confirmation that GLP-1 obesity treatments work not just in laboratories, but in living rooms. Released by the Digital Clinical Excellence Network, the DiCE REALM study found that patients accessing these drugs through regulated online clinics lost an average of 16 percent of their body weight over twelve months — results that rival controlled trials. Perhaps more striking is what the data suggests about who is being reached: people from ev